Tyrosine Sulfation Is a Trans-Golgi-Specific Protein Modification Patrick A

Total Page:16

File Type:pdf, Size:1020Kb

Tyrosine Sulfation Is a Trans-Golgi-Specific Protein Modification Patrick A Tyrosine Sulfation Is a trans-Golgi-specific Protein Modification Patrick A. Baeuerle and Wieland B. Huttner Cell Biology Program, European Molecular Biology Laboratory, 6900 Heidelberg, Federal Republic of Germany Abstract. The trans-Golgi has been recognized as heavy chain detectable by sulfate labeling, as well as having a key role in terminal glycosylation and sorting the heavy chain sulfated in a cell-free system in the of proteins. Here we show that tyrosine sulfation, a absence of vesicle transport, already contained galac- frequent modification of secretory proteins, occurs tose and sialic acid. Third, sulfate-labeled IgM moved specifically in the trans-Golgi. The heavy chain of im- to the cell surface with kinetics identical to those of munoglobulin M (IgM) produced by hybridoma cells galactose-labeled IgM. Lastly, IgM labeled with sul- was found to contain tyrosine sulfate. This finding al- fate at 20~ was not transported to the cell surface at lowed the comparison of the state of sulfation of the 20~ but reached the cell surface at 37~ The data heavy chain with the state of processing of its suggest that within the trans-Golgi, tyrosine sulfation N-linked oligosaccharides. First, the pre-trans-Golgi of IgM occurred at least in part after terminal glycosy- forms of the IgM heavy chain, which lacked galactose lation and therefore appeared to be the last modifica- and sialic acid, were unsulfated, whereas the trans- tion of this constitutively secreted protein before its Golgi form, identified by the presence of galactose and exit from this compartment. Furthermore, the results sialic acid, and the secreted form of the IgM heavy establish the covalent modification of amino acid side chain were sulfated. Second, the earliest form of the chains as a novel function of the trans-Golgi. major function of the Golgi complex is the covalent expect that the sulfation reaction should occur in one or more modification of proteins destined for lysosomes, of those compartments that are part of the secretory pathway, secretory granules, and the plasma membrane. Gol- i.e., the rough endoplasmic reticulum, the Golgi complex, gi-specific processing of asparagine-linked oligosaccharides and the various transport vesicles and storage granules. In- is particularly well characterized (for review see Kornfeld deed, a recent study indicated that after subcellular fraction- and Kornfeld, 1985; Farquhar, 1985). These reactions in- ation tyrosylprotein sulfotransferase activity is highest in clude (a) the specific removal of carbohydrate units, (b) the Golgi-enriched membrane fractions and that the active site addition of new carbohydrates, and (c) the addition of resi- of this membrane-bound enzyme is oriented toward the Gol- dues other than carbohydrates, such as phosphate to N-linked gi lumen (Lee and Huttner, 1985). oligosaccharides. The detailed characterization of these mod- Among the subcompartments of the Golgi, the trans-most ification reactions has contributed significantly to the under- structures, referred to as the trans-Golgi network (Grifliths standing of the structural and functional organization of the and Simons, 1986), have recently received a great deal of at- Golgi complex, which is currently viewed to comprise at tention. The trans-Golgi network has been proposed to have least three distinct subcompartments, the cis-, medial, and a key role in the sorting of lysosomal, plasma membrane, trans-Golgi (for reviews see Farquhar and Palade, 1981; Tar- and secretory proteins into membrane vesicles that transport takoff, 1982; Dunphy and Rothman, 1985; Farquhar, 1985). them to their specific destination. To understand the molecu- Compared with the information about the localization of pro- lar mechanisms involved in these sorting processes, it would cessing reactions involving N-linked oligosaccharides in the be helpful to identify protein components specific to the Golgi subcompartments, little is known about the localiza- trans-Golgi network. Such protein components would pro- tion of amino acid side chain modifications in the specific vide new markers for the trans-Golgi network that could subcompartments of the Golgi. be used for a more refined description of this compartment Recent work has indicated that the sulfation of tyrosine and that could also be employed for its isolation. Further- residues is a widespread protein modification and that secre- more, the characterization and comparison of several differ- tory proteins are the major physiological substrates for the ent trans-Golgi network-specific proteins may help to iden- sulfating enzyme(s) (Huttner, 1982; Hille et al., 1984; for re- tify domains on these proteins that are involved in their view see Huttner and Baeuerle, 1987). One would therefore specific localization and retention in the trans-Golgi net- Dr. Baeuede's present address is Whitehead Institute, Nine Cambridge Cen- work. Here, we report, using IgM as a model protein, that ter, Cambridge, MA 02142. tyrosine sulfation specifically occurs in the trans-Golgi and The Rockefeller University Press, 0021-9525/87/12/2655/10 $2.00 The Journal of Cell Biology, Volume 105 (No. 6, Pt. 1), Dec. 1987 2655-2664 2655 apparently is the last modification of this secretory protein a 10% CO2 atmosphere at 370C. Immediately after resuspension and after before its exit from the trans-Golgi. the times indicated, aliquots of the cell culture were removed and boiled in SDS-lysis buffer (see below), lgM was immunoaffinity-purified from the ly- sates as described in Immunoaffinity Purification of lgM and the radioactiv- Materials and Methods ity in the various forms of the IgM heavy chain determined by liquid scintil- lation counting after SDS-PAGE under reducing conditions. For pulse-labeling with pH]tyrosine, cells were resuspended at a den- Isotopes sity of 1 • l0 s cells/mi in labeling DME supplemented with 10% dialyzed FCS and allowed to equilibrate for 1 h in the incubator. Cells were then la- L-[3SS]methionine (carrier-free), L-[3,5-3H]tyrosine (1.5 TBq/mmol), L- beled for 10 rnin with 1.5 MBq/ml [3H]tyrosine, cooled on ice, and cen- [~C(U)]tyrosine (1.85 GBq/mmol), [3SS]sulfuric acid or sodium [3SS]sul- trifuged at 4~ for 10 rain at 150 g. The cells were resuspended in chase fate (carrier-free), L-[6-3H]fucose (0.93 TBq/mmol), v-[4,5JH(N)]galac - medium (complete DME, supplemented with 10% FCS) that had been pre- tose (1.7 TBq/mmol), and D-[2-3H(N)] mannose (0.89 TBq/mmol) were equilibrated in a 10% CO2 atmosphere at 37~ and distributed onto six obtained from New England Nuclear (Dreieich, FRG). 3'-Phosphoadeno- dishes that were immediately returned to the incubator. After the indicated sine 5'-phospho-[35S]sulfate (PAPS; 1 4.81 TBq/mmol) was kindly provided periods of chase, dishes were placed on ice. Cells and media were further by Christof Niehrs of this institution. processed as described in Immunoaffinity Purification of IgM. For pulse double-labeling, cells were resuspended at a density of 1 • Cell Culture 10s cells/ml in labeling DME supplemented with 0.1% dialyzed FCS and allowed to equilibrate for 1 h. Cells were then labeled with a mixture of 18.5 The hybridoma cell line studied is the clone 81-O4 of Sommer and Schach- MBq/ml [35S]sulfate and 12.3 MBq/ml [3H]galactose for 5 min in the incu- ner (1981), which secretes lgM directed against the cell surface antigen 04. bator. Thereafter the cell culture was immediately cooled on ice, and the Cells were grown at 37~ in complete DME (4.5 g/liter glucose) sup- cells were removed and collected by centrifugation at 4"C in a 50-ml tube plemented with 15% FCS (Gibco Laboratories, Karlsrnhe, FRG) in an at- (Falcon Labware). After a wash in ice-cold PBS, the cells were resuspended mosphere containing 10% C(h. For all labeling experiments, cells were at a density of 1 • 107 cells/mi in complete DME (supplemented with collected by centrifugation at 150 g for 5 min, washed once in ice-cold PBS, 0.1% FCS and 2 mM D(+)-galactose) that had been preequilibrated in a 10% and resuspended after centrifugation as described in the sections below. Un- CO2 atmosphere at 370C. Immediately after resuspension, two aliquots less indicated otherwise, labeling was performed in 3.5- or 5-cm petri dishes were removed and cooled on ice (zero time values). The cell suspension re- in a 10% CO~z incubator. For all labeling experiments we used labeling maining in the 50-ml Falcon tube was returned to the incubator and placed DME (sulfate-free and L-tyrosine-free) that was supplemented with 4.5 g/li- on a slowly rotating platform during the chase period. Further aliquots of ter glucose and 0.1-10% FCS dialyzed against 10 mM Hepes, pH 7.3 and the well-suspended cell culture were removed at the indicated times and im- 150 mM NaC1. To increase the efficiency of [35S]sulfate-labeling, a lower mediately placed on ice. Cells and media were further processed as de- concentration of L-methionine and L-cysteine (2% of normal) was used in scribed under Immunoaflinity Purification of IgM. some experiments (Baeuerle and Huttner, 1986). This had no detectable influence on protein synthesis as monitored by the incorporation of [3H]ty- rosine into proteins. 20~ Block Cells were resuspended in a 50-mi tube at a density of 1 x 107 cells/ml in Long-term Labeling labeling DME supplemented with 0.1% dialyzed FCS and allowed to equili- brate for 5 h on a slowly rotating platform in the incubator at 37~ The Cells were resuspended at a density of 1 x 107 cells/ml in labeling DME tube was then closed to preserve the atmosphere, removed from the incuba- supplemented with 0.1-10% dialyzed FCS.
Recommended publications
  • ECO-Ssls for Pahs
    Ecological Soil Screening Levels for Polycyclic Aromatic Hydrocarbons (PAHs) Interim Final OSWER Directive 9285.7-78 U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 June 2007 This page intentionally left blank TABLE OF CONTENTS 1.0 INTRODUCTION .......................................................1 2.0 SUMMARY OF ECO-SSLs FOR PAHs......................................1 3.0 ECO-SSL FOR TERRESTRIAL PLANTS....................................4 5.0 ECO-SSL FOR AVIAN WILDLIFE.........................................8 6.0 ECO-SSL FOR MAMMALIAN WILDLIFE..................................8 6.1 Mammalian TRV ...................................................8 6.2 Estimation of Dose and Calculation of the Eco-SSL ........................9 7.0 REFERENCES .........................................................16 7.1 General PAH References ............................................16 7.2 References Used for Derivation of Plant and Soil Invertebrate Eco-SSLs ......17 7.3 References Rejected for Use in Derivation of Plant and Soil Invertebrate Eco-SSLs ...............................................................18 7.4 References Used in Derivation of Wildlife TRVs .........................25 7.5 References Rejected for Use in Derivation of Wildlife TRV ................28 i LIST OF TABLES Table 2.1 PAH Eco-SSLs (mg/kg dry weight in soil) ..............................4 Table 3.1 Plant Toxicity Data - PAHs ..........................................5 Table 4.1
    [Show full text]
  • Biosynthesis and Secretion of the Microbial Sulfated Peptide Raxx and Binding to the Rice XA21 Immune Receptor
    Biosynthesis and secretion of the microbial sulfated peptide RaxX and binding to the rice XA21 immune receptor Dee Dee Luua,b,1, Anna Joea,b,c,1, Yan Chend, Katarzyna Paryse, Ofir Bahara,b,2, Rory Pruitta,b,3, Leanne Jade G. Chand, Christopher J. Petzoldd, Kelsey Longa,b, Clifford Adamchaka,b, Valley Stewartf, Youssef Belkhadire, and Pamela C. Ronalda,b,c,4 aDepartment of Plant Pathology, University of California, Davis, CA 95616; bThe Genome Center, University of California, Davis, CA 95616; cFeedstocks Division, Joint Bioenergy Institute, Emeryville, CA 94608; dTechnology Division, Joint Bioenergy Institute, Emeryville, CA 94608; eGregor Mendel Institute, Austrian Academy of Sciences, 1030 Vienna, Austria; and fDepartment of Microbiology & Molecular Genetics, University of California, Davis, CA 95616 Edited by Jonathan D. G. Jones, The Sainsbury Laboratory, Norwich, United Kingdom, and approved March 7, 2019 (received for review October 24, 2018) The rice immune receptor XA21 is activated by the sulfated micro- to Xoo strains lacking RaxX (7–10). Xoo strains lacking RaxX are bial peptide required for activation of XA21-mediated immunity X also compromised in virulence of rice plants lacking XA21 (10). (RaxX) produced by Xanthomonas oryzae pv. oryzae (Xoo). Muta- These results suggest a role for RaxX in bacterial virulence. tional studies and targeted proteomics revealed that the RaxX pre- Tyrosine sulfated RaxX16, a 16-residue synthetic peptide de- cursor peptide (proRaxX) is processed and secreted by the protease/ rived from residues 40–55 of the 60-residue RaxX precursor transporter RaxB, the function of which can be partially fulfilled by peptide (proRaxX), is the shortest characterized immunogenic a noncognate peptidase-containing transporter component B derivative of RaxX (10).
    [Show full text]
  • A Database for Enzymes Involved in Novel Post-Translational Modifications Shradha Khater and Debasisa Mohanty*
    Database, 2015, 1–12 doi: 10.1093/database/bav039 Original article Original article novPTMenzy: a database for enzymes involved in novel post-translational modifications Shradha Khater and Debasisa Mohanty* Bioinformatics Centre, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India *Corresponding author: Tel: þ91 11 26703749; Fax: þ91 11 26742125; Email: [email protected] Citation details: Khater,S. and Mohanty,D. novPTMenzy: a database for enzymes involved in novel post-translational modifications. Database (2015) Vol. 2015: article ID bav039; doi:10.1093/database/bav039 Received 7 November 2014; Revised 30 March 2015; Accepted 1 April 2015 Abstract With the recent discoveries of novel post-translational modifications (PTMs) which play important roles in signaling and biosynthetic pathways, identification of such PTM cata- lyzing enzymes by genome mining has been an area of major interest. Unlike well-known PTMs like phosphorylation, glycosylation, SUMOylation, no bioinformatics resources are available for enzymes associated with novel and unusual PTMs. Therefore, we have developed the novPTMenzy database which catalogs information on the sequence, struc- ture, active site and genomic neighborhood of experimentally characterized enzymes involved in five novel PTMs, namely AMPylation, Eliminylation, Sulfation, Hydroxylation and Deamidation. Based on a comprehensive analysis of the sequence and structural features of these known PTM catalyzing enzymes, we have created Hidden Markov Model profiles for the identification of similar PTM catalyzing enzymatic domains in gen- omic sequences. We have also created predictive rules for grouping them into functional subfamilies and deciphering their mechanistic details by structure-based analysis of their active site pockets. These analytical modules have been made available as user friendly search interfaces of novPTMenzy database.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, IRVINE an Expanded Genetic Code
    UNIVERSITY OF CALIFORNIA, IRVINE An expanded genetic code for the characterization and directed evolution of tyrosine-sulfated proteins DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILSOPHY in Biomedical Engineering by Xiang Li Dissertation Committee: Assistant Professor Chang C. Liu, Chair Associate Professor Wendy Liu Associate Professor Jennifer A. Prescher 2018 Portion of Chapter 2 © John Wiley and Sons Portion of Chapter 3 © Springer Portion of Chapter 4 © Royal Society of Chemistry All other materials © 2018 Xiang Li i Dedication To My parents Audrey Bai and Yong Li and My brother Joshua Li ii Table of Content LIST OF FIGURES ..................................................................................................................VI LIST OF TABLES ................................................................................................................. VIII CURRICULUM VITAE ...........................................................................................................IX ACKNOWLEDGEMENTS .................................................................................................... XII ABSTRACT .......................................................................................................................... XIII CHAPTER 1. INTRODUCTION ................................................................................................ 1 1.1. INTRODUCTION .................................................................................................................
    [Show full text]
  • NDA/BLA Multi-Disciplinary Review and Evaluation
    NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) NDA/BLA Multi-Disciplinary Review and Evaluation Application Type NDA Application Number(s) NDA 214154 (IND 110682) Priority or Standard Standard Submit Date(s) April 15, 2020 Received Date(s) April 15, 2020 PDUFA Goal Date April 15, 2021 Division/Office Division of Urology, Obstetrics, and Gynecology (DUOG) / Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM) Review Completion Date April 15, 2021 Established/Proper Name drospirenone and estetrol tablets (Proposed) Trade Name Nextstellis Pharmacologic Class Combination hormonal contraceptive Applicant Mayne Pharma LLC Dosage form Tablet Applicant proposed Dosing x Take one tablet by mouth at the same time every day. Regimen x Take tablets in the order directed on the blister pack. Applicant Proposed For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy Recommendation on Approval Regulatory Action Recommended For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy (if applicable) Recommended Dosing x Take one pink tablet (drospirenone 3 mg, estetrol Regimen anhydrous 14.2 mg) by mouth at the same time every day for 24 days x Take one white inert tablet (placebo) by mouth at the same time every day for 4 days following the pink tablets x Take tablets in the order directed on the blister pack 1 Reference ID: 4778993 NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) Table of Contents Table of Tables .................................................................................................................... 5 Table of Figures ................................................................................................................... 7 Reviewers of Multi-Disciplinary Review and Evaluation ...................................................
    [Show full text]
  • Biotransformation: Basic Concepts (1)
    Chapter 5 Absorption, Distribution, Metabolism, and Elimination of Toxics Biotransformation: Basic Concepts (1) • Renal excretion of chemicals Biotransformation: Basic Concepts (2) • Biological basis for xenobiotic metabolism: – To convert lipid-soluble, non-polar, non-excretable forms of chemicals to water-soluble, polar forms that are excretable in bile and urine. – The transformation process may take place as a result of the interaction of the toxic substance with enzymes found primarily in the cell endoplasmic reticulum, cytoplasm, and mitochondria. – The liver is the primary organ where biotransformation occurs. Biotransformation: Basic Concepts (3) Biotransformation: Basic Concepts (4) • Interaction with these enzymes may change the toxicant to either a less or a more toxic form. • Generally, biotransformation occurs in two phases. – Phase I involves catabolic reactions that break down the toxicant into various components. • Catabolic reactions include oxidation, reduction, and hydrolysis. – Oxidation occurs when a molecule combines with oxygen, loses hydrogen, or loses one or more electrons. – Reduction occurs when a molecule combines with hydrogen, loses oxygen, or gains one or more electrons. – Hydrolysis is the process in which a chemical compound is split into smaller molecules by reacting with water. • In most cases these reactions make the chemical less toxic, more water soluble, and easier to excrete. Biotransformation: Basic Concepts (5) – Phase II reactions involves the binding of molecules to either the original toxic molecule or the toxic molecule metabolite derived from the Phase I reactions. The final product is usually water soluble and, therefore, easier to excrete from the body. • Phase II reactions include glucuronidation, sulfation, acetylation, methylation, conjugation with glutathione, and conjugation with amino acids (such as glycine, taurine, and glutamic acid).
    [Show full text]
  • A Novel Method for Site-Determination of Tyrosine O- Sulfation in Peptides and Proteins
    A novel method for site-determination of tyrosine O- sulfation in peptides and proteins Yonghao Yu Genome Center, Depts of Chemistry and Molecular Cell Biology, University of California, Davis, CA, 95616 and Dept of Chemistry, University of California, Berkeley, CA, 94720, current address: Dept of Cell Biology, Harvard Medical School, Boston, MA 02115 Adam J. Hoffhines Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 Kevin L. Moore Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 Julie A. Leary Genome Center, Departments of Chemistry and Molecular Cell Biology, University of California, Davis, CA, 95616 Method Article Keywords: tyrosine sulfation, mass spectrometry, post-translational modication, protein-protein interaction, extracelluar matrix, proteomics Posted Date: September 20th, 2007 DOI: https://doi.org/10.1038/nprot.2007.388 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/12 Abstract Introduction Tyrosine O-sulfation is one of many posttranslational modications described in nature that can impart critical functional properties to proteins that are independent of the genes encoding them1, 2. It plays a key role in regulating protein-protein interactions in the extracellular space3 and is catalyzed by two closely related Golgi enzymes called tyrosylprotein sulfotransferases \(TPST-1 and TPST–2)4, 5. In this protocol, we describe a novel subtractive strategy to determine the sites of tyrosine sulfation in peptides and proteins6. Hydroxyl groups on unsulfated tyrosines are stoichiometrically acetylated by a one-step reaction using sulfosuccinimidyl acetate in the presence of imidazole at pH 7.0.
    [Show full text]
  • Tyrosine Sulfation: a Modulator of Extracellular Protein–Protein Interactions Provided by Elsevier - Publisher Connector John W Kehoe1 and Carolyn R Bertozzi1,2
    cm7309.qxd 03/10/2000 11:46 Page R57 CORE Minireview R57 brought to you by Elsevier - Publisher Connector Tyrosine sulfation: a modulator of extracellular protein–protein interactions provided by John W Kehoe1 and Carolyn R Bertozzi1,2 Tyrosine sulfation is a post-translational modification of P-selectin on activated endothelial cells with the many secreted and membrane-bound proteins. Its P-selectin glycoprotein ligand (PSGL)-1 on cognate biological roles have been unclear. Recent work has leukocytes [3]. PSGL-1 was identified at the molecular implicated tyrosine sulfate as a determinant of level in 1993, using expression cloning [4]. Glycosylation protein–protein interactions involved in leukocyte of PSGL-1 was known to be a major determinant of adhesion, hemostasis and chemokine signaling. P-selectin binding, but was not sufficient to explain the binding avidities observed in vivo. Addresses: Departments of 1Molecular and Cell Biology and 2 Chemistry, University of California, Berkeley, CA 94720, USA. Further investigations revealed that tyrosine sulfation near Correspondence: Carolyn R Bertozzi the amino terminus of PSGL-1 plays an essential role in E-mail: [email protected] P-selectin binding (shown schematically in Figure 1b). Three papers published within one month of each other in Chemistry & Biology 2000, 7:R57–R61 1995 provided the first evidence of this phenomenon 1074-5521/00/$ – see front matter [5–7]. Progressive deletions of the PSGL-1 amino termi- © 2000 Elsevier Science Ltd. All rights reserved. nus by Pouyani and Seed [5] revealed that a 20-residue peptide was required for high-affinity binding. Further- The study of living systems has been transformed by an more, mutagenesis within this sequence showed that the explosion of genetic information.
    [Show full text]
  • NST110: Advanced Toxicology Lecture 4: Phase I Metabolism
    Absorption, Distribution, Metabolism and Excretion (ADME): NST110: Advanced Toxicology Lecture 4: Phase I Metabolism NST110, Toxicology Department of Nutritional Sciences and Toxicology University of California, Berkeley Biotransformation The elimination of xenobiotics often depends on their conversion to water-soluble chemicals through biotransformation, catalyzed by multiple enzymes primarily in the liver with contributions from other tissues. Biotransformation changes the properties of a xenobiotic usually from a lipophilic form (that favors absorption) to a hydrophilic form (favoring excretion in the urine or bile). The main evolutionary goal of biotransformation is to increase the rate of excretion of xenobiotics or drugs. Biotransformation can detoxify or bioactivate xenobiotics to more toxic forms that can cause tumorigenicity or other toxicity. Phase I and Phase II Biotransformation Reactions catalyzed by xenobiotic biotransforming enzymes are generally divided into two groups: Phase I and phase II. 1. Phase I reactions involve hydrolysis, reduction and oxidation, exposing or introducing a functional group (-OH, -NH2, -SH or –COOH) to increase reactivity and slightly increase hydrophilicity. O R1 - O S O sulfation O R2 OH Phase II Phase I R1 R2 R1 R2 - hydroxylation COO R1 O O glucuronidation OH R2 HO excretion OH O COO- HN H -NH2 R R1 R1 S N 1 Phase I Phase II COO O O oxidation glutathione R2 OH R2 R2 conjugation 2. Phase II reactions include glucuronidation, sulfation, acetylation, methylation, conjugation with glutathione, and conjugation with amino acids (glycine, taurine and glutamic acid) that strongly increase hydrophilicity. Phase I and II Biotransformation • With the exception of lipid storage sites and the MDR transporter system, organisms have little anatomical defense against lipid soluble toxins.
    [Show full text]
  • Tyrosine Sulfation: a Post-Translational Modification of Proteins Destined for Secretion?
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 177, number 1 FEBS 1967 November 1984 Tyrosine sulfation: a post-translational modification of proteins destined for secretion? A. Hille, P. Rosa and W.B. Huttner* Max-Planck-Institute for Psychiatry, Department of Neurochemistry, Am Klopferspitz 18a, 8033 Martinsried, FRG Received 21 August 1984 Protein sulfation was studied in germ-free rats by prolonged in vivo labeling with [35S]sulfate. Specific sets of sulfated proteins were observed in all tissues examined, in leucocytes, and in blood plasma. No protein sulfation was detected in erythrocytes. Analysis of the type of sulfate linkage showed that sulfated proteins secreted into the plasma contained predominantly tyrosine sulfate, whereas sulfated proteins found in tissues contained largely carbohydrate sulfate. This implies some kind of selection concerning the intracellular pro- cessing, secretion, turnover or re-uptake of sulfated proteins which is responsible for the enrichment of tyro- sine-sulfated proteins in the plasma. Tyrosine sulfate Protein sulfation Protein secretion Plasma protein Germ-free rat 1. INTRODUCTION Here we have used prolonged [35S]sulfate label- ing of germ-free rats to analyze the tyrosine sulfate Sulfation of tyrosine residues is a widespread content of proteins in various tissues and in the post-translational modification of proteins [ 11. blood plasma, a body fluid known to consist Tyrosine-sulfated proteins have been observed not almost exclusively of secretory proteins. We found only in many tissues in mammals [ 11, but also in all the highest level of tyrosine sulfate in plasma pro- vertebrate and invertebrate metazoa studied so far, teins.
    [Show full text]
  • 6. References
    332 IARC MONOGRAPHS VOLUME 91 6. References Abramov, Y., Borik, S., Yahalom, C., Fatum, M., Avgil, G., Brzezinski, A. & Banin, E. (2004) The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause, 11, 62–68 Adams, M.R., Register, T.C., Golden, D.L., Wagner, JD. & Williams, J.K. (1997) Medroxyproges- terone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler. Thromb. vasc. Biol., 17, 217–221 Adjei, A.A. & Weinshilboum, R.M. (2002) Catecholestrogen sulfation: Possible role in carcino- genesis. Biochem. biophys. Res. Commun., 292, 402–408 Adjei, A.A., Thomae, B.A., Prondzinski, J.L., Eckloff, B.W., Wieben, E.D. & Weinshilboum, R.M. (2003) Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: Gene resequencing and functional genomics. Br. J. Pharmacol., 139, 1373–1382 Ahmad, M.E., Shadab, G.G.H.A., Hoda, A. & Afzal, M. (2000) Genotoxic effects of estradiol-17β on human lymphocyte chromosomes. Mutat. Res., 466, 109–115 COMBINED ESTROGEN−PROTESTOGEN MENOPAUSAL THERAPY 333 Ahmad, M.E., Shadab, G.G.H.A., Azfer, M.A. & Afzal, M. (2001) Evaluation of genotoxic poten- tial of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. Mutat. Res., 494, 13–20 Aitken, J.M., Hart, D.M. & Lindsay, R. (1973) Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br. med. J., 3, 515–518 Al-Azzawi, F., Wahab, M., Thompson, J., Whitehead, M. & Thompson, W. (1999) Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: A dose-ranging study. Hum. Reprod., 14, 636–641 Albert, C., Vallée, M., Beaudry, G., Belanger, A.
    [Show full text]
  • Serves As High-Affinity Substrate for Tyrosylprotein Sulfotransferase
    Proc. Nati. Acad. Sci. USA Vol. 82, pp. 6143-6147, September 1985 Cell Biology (Glu62,Ala30,Tyr8). serves as high-affinity substrate for tyrosylprotein sulfotransferase: A Golgi enzyme (tyrosine sulfation/protein sorting/chromaffin granules/tyrosine phosphorylation/tubulin) RAYMOND W. H. LEE AND WIELAND B. HUTTNER* Department of Neurochemistry, Max-Planck-Institute for Psychiatry, 8033 Martinsried, Federal Republic of Germany Communicated by Fritz Lipmann, May 10, 1985 ABSTRACT Tyrosylprotein sulfotransferase, the enzyme as substrate are as follows: (i) the only sulfatable hydroxyl catalyzing the sulfation of proteins on tyrosine residues, was group in Glu,Ala,Tyr is on tyrosine, in contrast to physio- characterized by using the acidic polymer containing tyrosine logical protein substrates, which may also contain sulfatable (Glu62,Ala3',Tyr8). (referred to as Glu,Ala,Tyr) as exogenous carbohydrate, serine, and threonine residues; (ii) "protein" substrate. After subcellular fractionation ofa bovine Glu,Ala,Tyr is available in completely unsulfated form in adrenal medulla homogenate, tyrosylprotein sulfotransferase sufficient quantities for enzymological studies, whereas activity was found to be highest in fractions enriched in Golgi physiologically sulfated proteins purified from bi6logical membrane vesicles. Tyrosylprotein sulfotransferase required sources need to be desulfated before being used as sub- the presence of a nonionic detergent for sulfation of exogenous strates; (iii) Glu,Ala,Tyr is likely to contain tyrosine residues Glu,Ala,Tyr, indicating an orientation of the catalytic site of in the vicinity ofacidic amino acid residues. A comparison of the enzyme toward the Golgi lumen. Tyrosylprotein the amino acid sequences surrounding the sulfated tyrosine sulfotransferase was solubilized by Triton X-100, suggesting residues in gastrin (10), cholecystokinin (11), fibrinopeptide that the enzyme was tightly associated with the Golgi mem- B (12), and hirudin (13) shows that these sequences always brane, possibly as an integral membrane protein.
    [Show full text]